This shift also poses challenges for countries that supply a large proportion of U.S
Pfizer's acquisition of Metsera signals strong commercial interest
These changes in weight and body composition increase the risk for cardiometabolic diseases, as evidenced by the increased prevalence of type 2 diabetes, dyslipidemia, metabolic dysfunction-associated steatotic liver disease (MASLD-previously referred to as nonalcoholic fatty liver disease) and cardiovascular disease (CVD) after menopause. How was the study set up
Month 12) were studied using 16S ribosomal RNA gene sequencing and analysis
If your doctor asks why you are interested in GLP-1 medications specifically, be ready with this: "I understand that GLP-1 receptor agonists work on the neurohormonal pathways that regulate appetite and glucose metabolism
Torres-Obreque KM, Meneguetti GP, Muso-Cachumba JJ, Feitosa VA, Santos JHPM, Ventura SPM, et al